| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102656
Status
Published
Date of creation
2011-11-01 19:24 UTC (andrew.bowers@cbd.int)
Date of last update
2011-11-21 16:11 UTC (andrew.bowers@cbd.int)
Date of publication
2011-11-21 16:11 UTC (andrew.bowers@cbd.int)

This document is also available in the following languages:
Origin of report
Country
  • Tunisia
Contact officer for report
Coordinates
Salem Hamdi
Secrétaire d'Etat auprès du Ministre de l'Agriculture et de l'Environnement
Ministère de l'Agriculture et de l'Environnement
BV de la Terre 1080
Ariana
Tunisia
Phone:+216 70728644,+21670728694
Fax:+21670728655
Email:pfn.pca@mineat.gov.tn
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
FR
Ce rapport a été établi en concertation avec les différents organismes et institutions concernés notamment : les départements chargés  de l'Agriculture, de l'Enseignement, de la Recherche, de la Santé, du commerce… et  certaines personnes ressources; et ce à travers :

- Les Avis des différents départements concernés sur les thèmes du présent rapport.
- des contacts directs avec les différents intervenants,
- des réunions restreintes avec certains membres du comité National de la Biosécurité,
- les documents et les rapports disponibles  qui ont été élaborés par les différents intervenants dans le domaine.,
Submission
10. Date of submission
2011-10-31
11. Time period covered by this report
Start date
2008
Time period covered by this report
End date
2011
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • Only a draft framework exists
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
  • One or more national biosafety regulations
  • One or more sets of biosafety guidelines
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • No
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • No
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • No
21. Here you may provide further details on the implementation of Article 2 in your country:
FR
La Tunisie a  pris des mesures juridiques, administratives et autres nécessaires à la mise en œuvre du Protocole à savoir :

- la mise en place d'un comité national ad hoc sur la biosécurité en 1999 et qui  attend sa création officielle par décret,

- l'élaboration d'une étude sur les biotechnologies en Tunisie en 2000 ,
- la ratification du protocole en janvier 2003

- la préparation d'un cadre juridique national sur la biosécurité (en cours d'adoption)  qui permettra d'encadrer et de contrôler de manière adéquate l'utilisation confinée, la dissémination volontaire, la mise sur le marché, l'importation et le transit des OVM.

- l'élaboration d'une stratégie et un plan d"action sur la biosécurité en 2009,

- le renforcement des capacités atravers des sessions de formation,

- la mise en place d'un laboratoire de référence de detection et de quantification des OVM (non encore operationel)
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • Yes
26. Does your country regulate the contained use of LMOs?
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • No
28. Here you may provide further details on the implementation of Article 6 in your country:
FR
Des réglementations et des procédures relatives au transit et à l'utilisation des OVM en milieu confiné ont été inscrites dans le projet du cadre national sur la biosécurité (déjà élaboré); toutefois, la loi nationale sur la biosécurité n'étant pas encore adoptée par le parlement, ce cadre n'est pas encore appliqué.
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • No
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • No
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
32. If you answered Yes to question 31, does the mechanism also apply to cases of intentional introduction of LMOs into the environment that were not subject to transboundary movement?
  • Yes
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • Yes
34. Does your country have the capacity to detect and identify LMOs?
  • Yes, to some extent
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • Yes
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • Yes
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
FR
Des réglementations et de procédures relatives aux articles 7-10 ont été établi. Cela engloble des textes d'applications relatifs aux notifications qui doivent être adressées pour la mise sur le marché, l'utilisation confinée, le transit d'OVM. Toutefois, le cadre juridique n'étant pas toujours officiellement adopté par les instances gouvernementales, de telles procédures ne sont pas encore appliquables.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • No
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • Yes
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • Yes
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • Yes
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
FR
Des textes et procédures réglementaires relatives à l'article 11 ont été établi mais non encore adoptés par le parlement et n'est pas entré en vigueur. S'agissant des mesures à prendre en cas d'absence de certitude scientifique concernant les effets nuisibles potentiels des OVM concernés, les décisions seront prises à la lumière des données scientifiques disponibles. La Commission Nationale de Biosécurité analysera les dossiers cas par cas.
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • Yes
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
FR
Les textes juridiques de la loi nationale de biosécurité prévoient que l'autorisation d'un OVM particulier est limitée dans le temps. Par ailleurs, il est également prévu que la Commission Nationale de Biosécurité à toute la latitutde, suite à la parution de nouvelles données scientifiques, de retirer l'autorisation d'un OVM donné.

La loi n'est pas encore entrée en vigueur. Aucun OVM n'a été encore autorisé. Aucune  reconsidération d'approbation n'a donc été effectuée.
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
FR
Cette procédure simplifiée n'a pas été prévue dans les textes et procédures réglementaires proposés dans la stratégie et le plan d'action (déjà élaborés).
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
80. Here you may provide further details on the implementation of Article 14 in your country:
FR
A ce jour, il n'y a pas d'accords ou arrangements bilatéraux ou multilatéraux régissant les mouvements transfrontaliers intentionnels d'organismes génétiquement modifiés.
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes
82. If you answered Yes to question 81, does this mechanism include procedures for identifying experts to conduct the risk assessments?
  • Yes
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • Yes
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • No
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • Yes
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Not applicable
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • No
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • Not applicable
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Not applicable
93. Here you may provide further details on the implementation of Article 15 in your country:
FR
L'évaluation des risques a été prévue dans les textes et procédures réglementaires proposés dans le cadre national sur la biosécurité (déjà élaboré) y compris les services concernés. Par ailleurs, un organisme national de référence sera mis en place pour assurer l'évaluation des risques, dont ceux relatifs aux OVMs
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • Yes, to some extent
94.2) LMOs intended for direct use as food or feed, or for processing?
  • Yes, to some extent
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • Yes, to some extent
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
FR
La gestion des risques a été prévue dans les textes et procédures réglementaires proposés dans le plan d'action national sur la biosécurité (déjà élaboré) mais aucune application n'a été faite jusqu'à aujourdh'hui étant donné que la loi nationale sur la biosécurité n'a pas encore été adoptée.
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • No
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • Yes
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
FR
Les mesures d'urgences prévues dans les textes et procédures réglementaires proposés dans le plan d'action national sur la biosécurité (déjà élaboré) concernent les risques potentiels des OVM de façon globale.
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • Yes
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • Yes
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • Yes
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
114. Has your country established procedures for the sampling and detection of LMOs?
  • Yes, to some extent
115. Here you may provide further details on the implementation of Article 18 in your country:
FR
Le cadre juridique national prévoit que les demandes d'autorisation de mise sur le marché, d'utilisation confinée ou de transit des OVM soient antérieures à leur importation. La loi exigera que les OVM autorisés soient accompagnés de documents dont la nature exacte sera indiquée dans les textes d'application. Les OVM non autorisés ne pourront pas être introduits
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, some information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes, to some extent
123. Here you may provide further details on the implementation of Article 19 in your country:
FR
Le Ministère chargé de l'Environnement et le Président de la Commission Nationle de Biosécurité est l'autorité nationale compétente chargée de l'application des dispositions relatives à l'article 19 du Protocole
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available but not in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available but not in the BCH
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available but only partially available in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available but not in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • Yes
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • No
128. Has your country experienced difficulties accessing or using the BCH?
  • No
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Not applicable
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
FR
Le BCH national est mis en place mais non encore mis en ligne étant donné que le cadre juridique n'a pas encore été adopté par le parlement. A l'entrée en force du cadre juridique, celui ci, ainsi que les textes d'application, les guides techniques, les supports de sensibilisation et toutes les autres données liées à la biosécurité telles que la liste des OVMs autorisés seront disponibles sur le portail du BCH national
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • No
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • In some cases only
134. Here you may provide further details on the implementation of Article 21 in your country:
FR
la loi prévoit que les informations relatives à un OVM donné deviennent publiques après leur autorisation.
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Regional channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Average
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Implementation of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
  • Building Capacity for Effective Participation in the BCH (Phase II)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Institutional capacity
  • Human resources capacity development and training
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Identification of LMOs, including their detection
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • Yes
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
FR
La Tunisie a bénéficié respectivement :

* D'un projet FEM/GEF pour la mise en place du cadre national sur la biosécurité (études sur la biotechnologie en Tunisie, sur la stratégie et plan d'action en biosécurité et préparation du cadre juridique) (1997 - 2000)

* D'un projet   " renforcement des capacités en vue d'une participation efficace au BCH  (BCH1)"

* D'un projet de renforcement des capacités pour la mise en œuvre du cadre national de biosécurité  est en cours de mise en œuvre depuis janvier 2007 (financement: GEF, Agence d'exécution: PNUE, Agence de mise en œuvre: Ministère de l'Agriculture et de l'Environnement / Direction Générale de l'Environnement et de la Qualité de la Vie),

* D'un projet   " renforcement des capacités en vue d'une participation efficace au BCH 2  (en cours)",

* Du projet relatif à la préparation du 2ème rapport national de mise en œuvre du protocole,

Le processus d'obtention des fonds est parfois assez lent notamment pour le projet de mise en place du cadre national de biosécurité et le projet de mise en œuvre de ce cadre. Alors que  pour que les projets BCH1, BCH2 et le 2ème rapport national le processus est normal.

Certains étudiants et chercheurs nationaux ont bénéficié de formations scientifiques et techniques en matière de prévention des risques biotechnologiques dans des établissements et des labos à l'étranger,

Des cours en matière de biosécurité sont effectués dans certains établissements universitaires,

Des mémoires de fin d'études sont réalisées dans certaines établissements universitaires entre autre pour des thèmes liées aux aspects juridiques ou techniques tels que le développement de modèles de notification.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
152. Has your country established a biosafety website?
  • No
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • Yes, to a limited extent
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • Yes
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • No
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to a limited extent
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • Yes
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
FR
Les textes d'application du projet de loi en voie de promulgation comprennent plusieurs dispositions visant l'information du public concernant les OVM. Le notifiant doit fournir des données qui seront accessibles au grand public. Par ailleurs, le BCH sera un des supports pour la dissémination de l'information concernant les OVM ayant obtenus l'autorisation préalable du Minisitère chargé de l'Environnement.

Par ailleurs, la société civile est représentée au niveau de la Commission Nationale de Biosécurité (CNB) à travers l'Agence de Défense des Consommateurs. C'est à travers cette agence, membre permanent du CNB que le public prend part dans la prise de décision dans les autorisations de mise sur le marché des OVM.
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • Yes
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • Yes
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Yes
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • Yes
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • No
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • No
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • Lack of financial resources to gather the necessary information
  • Difficulty in compiling the information from various sectors
  • le rapport a été établi après les délais et non soumis au secretariat.
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
FR
- Certains sujets sont en phase d'études et certains processus sont en cours d'enclenchement, telles que l'adoption et l'entrée en vigueur du cadre juridique national.

- Les informations sont parfois indisponibles et la mise en place d'un BCH (national) permettra de réaliser une base de données dynamique avec la participation des différents acteurs compétents dans le domaine.

- Le projet PNUE/GEF de mise en œuvre du cadre national de la biosécurité permettra d'accélérer la mise en œuvre des différentes dispositions du protocole.

- La réalisation de l'étude sur l'état des lieux des biotechnologies modernes en Tunisie, l'élaboration d'une stratégie et d'un plan d'action sur la biosécurité, l'élaboration des textes d'applications du cadre juridique et les procédures constituent une plate forme intéressante pour la mise en application du protocole.

- L'entrée en vigueur du cadre juridique après son adoption permettra la mise en application effective du protocole et par la suite la réponse aux différentes questions figurant dans le rapport sera plus aisée.

Re: Q. 14 - la Tunisie à ratifié le protocole le 22 janvier 2003

Re: Q. 135 -

- Formation de capacités et appui à la mise en place d'une unité de contrôle des semences (non encore opérationnel) au niveau du service contrôle de semences et plants
- Participation à des stages et réunions coordonnées par des organismes telque  le Joint Research Centre ou encore l'Intetnational Centre of Agricultural Research in Dry Area.

Re: Q. 136 - Voies multilatérales aussi
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
FR
Pas de difficultés particulières. Toutefois et selon notre avis le Parties peuvent être classés dans trois catégories différentes :

-   une situation ou l'application effective du cadre national de biosécurité est en cours,

- une situation intermédiaire ou le cadre  national de biosécurité a été élaboré mais dont l'application n'a pas encore démarré,

- une situation ou le cadre national de biosécurité n'est pas encore élaboré,
La situation intermédiaire est la catégorie ou on peut rencontrer parfois  des difficultés à répondre aux différentes questions de la présente requête. La Tunisie en fait partie.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2003
Here you may provide further details
FR
For the national contribution in the project "Support for Implementation of the National Biosafety Framework for Tunisia" the gouvernment  provides 75,000 US$ in the last four years
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • 5 per year or more
Here you may provide further details
FR
A/ We integrated at the national level an academic courses at the national university dealing with biosafety program  such us: Nutrition Institute, Biotechnology Center of Sidi thabet, National Institute of Applicated Technolgy,  Ect....    B/ Holding a series of training couses, engaged by the ministry charged of environement , such us:    - Risk assessment & management from 10 to 14 december 2012;  - Notification & handling requests from 17 to 19 december 2012.                   - GMO detection & quantification from 24 to 29 november 2012 ,  in collaboration with the Center of Biotechnology Sfax  (bioprotech project);    - Arrange an overseas training courses: visit of the national biosafety committee to the national institute of health of belguim  for legal & administrative subject (11 persons were participated to this visit ) this visit was done on 14 september 2012.    - Handling a training course for 12 persons to visit SCL Strasbourg for GMO detection and quantification: From 4 to 8 february 2013 (group1) & from 11 to 15 february 2013 (group 2)     - Handling a public awareness activities " the National Days for biodiversity & biosafety - Tunis from 27 to 31 may 2013"
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • Yes
Here you may provide further details
FR
The Overall Goal of the  project is that Tunisia will have a workable, responsive and transparent NBF, which is in line with its national development priorities, the Cartagena Protocol and other international obligations. in this case we developped a national network for coordinating biosafety capacitity building initiatives :     - A technical  & scientific biosafety commitee;  - A national network for laboratories detection & quantification.
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 50,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • No
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • No
Survey 9.b) Risk management
  • No
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • No
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • No
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • No
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • Yes
Survey 13.c) Monitor
  • Yes
Here you may provide further details
FR
we said in the response both yes & No because we have a national capacities for identification, assesment and monitoring but  they need strengthening their capacities in these areas.
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • Yes
Here you may provide further details
FR
But still a draft document , it was an order ensuring the safe handling, transport and packaging of Living Modified Organisms.
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • No
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • None
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
FR
N/A
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • No
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • 10 or more
Survey 19.b) Monitoring
  • 10 or more
Survey 19.c) Management / Control
  • 10 or more
Here you may provide further details
FR
as we mentionned before we done a series of training sesions in these fields and in each session we trained approximately 25 persons representative of different ministry and institution dealing with risk assessment, monitoring, management & control.
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • Yes
Here you may provide further details
FR
we created a national network for laboratories detection & quantification composed of:  -              The technical center of food analysis;  - The laboratory of seed detection at the ministry of agriculture;  - The central laboratory of analysis;  -              The national Gene Bank.    But these laboratories are still not certificated
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • Yes
Here you may provide further details
FR
we have two kinds of training materials:  1/ training material elaborated by the sec-CBD  2/ national technical guides for risk assesment & management.
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • Yes
Survey 22.b) Effective
  • Yes
Here you may provide further details
FR
these technical guides need more details "case by case"
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • One or more
Here you may provide further details
FR
in each training session we have one or two customs officers in the team
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • 10 or more
Here you may provide further details
FR
In each training session we have many representative of  our national network for laboratories detection
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • No
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • None
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • None
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • Yes
Here you may provide further details
FR
it was an activity in the GEF / UNEP project on the Support for Implementation of the National Biosafety Framework for Tunisia: GFL-2328-2716-4953 GF/3010-06-14
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • No
Here you may provide further details
FR
the process is ongoing
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • No
Here you may provide further details
FR
the process is ongoing
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • N/A
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • 5 or more
Here you may provide further details
FR
-Biotechnology Center of Sfax (training courses & programmes);  - Biotechnology Center of Borj Cedria (education, training courses & pogrammes);  - Biotechnology Institute of Sidi Thabet (education);  - University of science Tunis (education);  - National Institute of Nutrition (education master degree);   - Institut Pasteur Tunis (Programmes), ect..
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • One or more
Here you may provide further details
FR
some training materials are developped in the project "Support for Implementation of the National Biosafety Framework for Tunisia" such us:   - Risk assesment & management;  - Notification procuders.  but they are not an online modules, they are available at the Ministry charged of environment
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • Yes
Survey 35.b) Enforcement system
  • Yes
Here you may provide further details
FR
the process is ongoing we elaborated a draft document
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • 5 or more
Here you may provide further details
FR
1/ Training course on: Risk assessment & management from 10 to 14 december 2012 (Tunis);  -2/ Training course on:Notification & handling requests from 17 to 19 december 2012 (Tunis);               - 3/ Training course on:GMO detection & quantification from 24 to 29 november 2012 (Sfax) ,  in collaboration with the Center of Biotechnology Sfax  (bioprotech project);    -4/  Arrange an overseas training courses: visit of the national biosafety committee to the national institute of health of belguim  for legal & administrative subject (11 persons were participated to this visit ) this visit was done on 14 september 2012;    - 5/ Handling a training course for 12 persons to visit SCL Strasbourg for GMO detection and quantification: From 4 to 8 february 2013 (group1) & from 11 to 15 february 2013 (group 2);     - 6/ Handling a public awareness activities " the National Days for biodiversity & biosafety - Tunis from 27 to 31 may 2013";   - 7/ BCH training workshop from 11 to 12 mars 2013 for the media & civil society (Tunis);  - 8/  BCH training workshop from 13 to 15 mars 2013 for the universities & research institutions (Tunis);  - 9/ BCH training workshop from 12 to 14 november 2012 for the main stackeholders (Tunis);
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • None
Here you may provide further details
FR
National technical guidelines on biosafety:  1/ Risk assesment & management;  2/ tracability & Gmo detection;  3/ Notification & handling requests;  4/ National Strategy & action plan on biosafety;    5/ National legal framework on biosafety.
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • All the documents are available at the ministry charged of environement. We will programmed to posted it on the BCH National website (the process is ongoing)
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • 5 or more
Here you may provide further details
FR
The initiative UNEP / GEF for :     A / Support for Implementation of the National Biosafety Framework for Tunisia: GFL-2328-2716-4953 GF/3010-06-14  B/ UNEP/GEF Project for Building Capacity for Effective Participation in the Biosafety Clearing House  C/ Bioprotech project for Tunisia "ICGEB, INSA, genepole & bioindustry park"
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • Yes
Here you may provide further details
FR
The process is ongoing
Survey 41. If you answered yes to the question above, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place.
indicator 5.3.1
E.g. local, national, etc.,
FR
the program will be adress for the different levels:  - Academic & scientists;  - Media & NGOs;  - gouvernment, ect...
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • No
Here you may provide further details
FR
The process is ongoing
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • 5 or more